ANIP News and Press, ANI Pharmaceuticals Inc.

2026-07-09 17:56:46 ET Stephen Carey, SVP & CFO of ANI Pharmaceuticals (NASDAQ:ANIP) , reported the sale of 2,850 shares of common stock in an open-market transaction on June 29, according to a SEC Form 4 filing . The transaction and post-transaction values based on Ju...

2026-06-26 10:26:34 ET ANI Pharmaceuticals ( ANIP ) is a speculative Buy because you have to clearly understand what you are buying. You are not just buying a quarterly estimate beat, or a share repurchase or a one-time licensing fee. The bull case is mainly about Cortrophin Gel.......

2026-06-01 13:25:09 ET Image source: The Motley Fool. Friday, May 8, 2026, 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference as follows: The live and archived ...

2026-05-11 17:29:29 ET According to a Securities and Exchange Commission (SEC) filing dated May 11, 2026, Global Alpha Capital Management Ltd. sold 228,895 shares of Ani Pharmaceuticals (NASDAQ:ANIP) in the first quarter. The estimated transaction value was $17.87 million, calcu...

2026-05-08 12:52:39 ET More on ANI Pharmaceuticals ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript ANI Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation ANI Pharmaceuticals Looks Undervalued As Cortrophin Drives Rare Disease Growt...

2026-05-08 12:51:21 ET ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call May 8, 2026 8:00 AM EDT Company Participants Irina Koffler Nikhil Lalwani - President, CEO & Director Christopher Mutz - Senior Vp & Head of Rare Disease Stephen Carey - Sen...

2026-05-08 06:54:30 ET More on ANI Pharmaceuticals ANI Pharmaceuticals Looks Undervalued As Cortrophin Drives Rare Disease Growth ANI Pharmaceuticals: Worthy Of A Position ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference ...

Quarterly net revenues of $237.5 million, an increase of 20.5% year-over-year Purified Cortrophin ® Gel net revenues of $75.1 million, an increase of 42.1% year-over-year Quarterly GAAP net income available to common shareholders of $29.5 million; Quarterly a...

2026-05-07 15:10:43 ET More on ANI Pharmaceuticals ANI Pharmaceuticals Looks Undervalued As Cortrophin Drives Rare Disease Growth ANI Pharmaceuticals: Worthy Of A Position ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference ...